Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Abdul M. Oseini"'
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
Autor:
Yi Luo, Samir Wadhawan, Alex Greenfield, Benjamin E. Decato, Abdul M. Oseini, Rebecca Collen, Diane E. Shevell, John Thompson, Gabor Jarai, Edgar D. Charles, Arun J. Sanyal
Publikováno v:
Hepatology Communications, Vol 5, Iss 5, Pp 760-773 (2021)
Nonalcoholic steatohepatitis (NASH) is a major cause of liver‐related morbidity and mortality worldwide. Liver fibrosis stage, a key component of NASH, has been linked to the risk of mortality and liver‐related clinical outcomes. Currently there
Externí odkaz:
https://doaj.org/article/8a3abd3b1df443e39f2096123e2609aa
Autor:
Essa A. Mohamed, Nasra H. Giama, Hassan M. Shaleh, Linda Kerandi, Abdul M. Oseini, Hager Ahmed Mohammed, Henry Kerandi, Loretta K. Allotey, Ibrahim A. Waaeys, Hamdi A. Ali, Hawa M. Ali, Safra A. Mohamed, Ju Dong Yang, Wudneh O. Gaga, Lily L. Tamire, Awol Windissa, Christi A. Patten, Joyce E. Balls-Berry, Lewis R. Roberts
Publikováno v:
Frontiers in Public Health, Vol 8 (2020)
Background: In the United States, hepatocellular carcinoma is the ninth leading cause of cancer mortality. Hepatocellular carcinoma disproportionately affects individuals of African ancestry with the rates being higher amongst individuals of foreign-
Externí odkaz:
https://doaj.org/article/21ecde234b2f4e02a806e5b1ae3533da
Autor:
Lewis R. Roberts, Martin E. Fernandez-Zapico, Vijay H. Shah, Eric Chevet, Snorri S. Thorgeirsson, Ju-Seog Lee, Tao Song, Dehai Wu, Shaoqing Wang, Hassan M. Shaleh, Dongye Yang, Yong Fang, Yichun Chen, Abdul M. Oseini, Bubu A. Banini, Chunling Hu, Shaoshan Han, Catherine D. Moser, Michael K. Asiedu, Mengtao Zhou, Roongruedee Chaiteerakij, Alexander G. Miamen, Luciana L. Almada, Renzo E. Vera, Paola A. Romecin, Ezequiel J. Tolosa, Eriko Iguchi, Renumathy Dhanasekaran, Ikuo Nakamura, Gang Chen
Legends for Supp Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588edc8f1240513130701c6be4a8ac33
https://doi.org/10.1158/0008-5472.22412183.v1
https://doi.org/10.1158/0008-5472.22412183.v1
Autor:
Lewis R. Roberts, Martin E. Fernandez-Zapico, Vijay H. Shah, Eric Chevet, Snorri S. Thorgeirsson, Ju-Seog Lee, Tao Song, Dehai Wu, Shaoqing Wang, Hassan M. Shaleh, Dongye Yang, Yong Fang, Yichun Chen, Abdul M. Oseini, Bubu A. Banini, Chunling Hu, Shaoshan Han, Catherine D. Moser, Michael K. Asiedu, Mengtao Zhou, Roongruedee Chaiteerakij, Alexander G. Miamen, Luciana L. Almada, Renzo E. Vera, Paola A. Romecin, Ezequiel J. Tolosa, Eriko Iguchi, Renumathy Dhanasekaran, Ikuo Nakamura, Gang Chen
Supplementary Table 1 List of antibodies, reagents and kits used in the study Supplementary Table 2 List of primers used in the study Supplementary Table 3 Comprehensive literature search of angiogenic regulators in HCC Supplementary Table 4 Correlat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f277ce2ab06485a9cee18157182cc6
https://doi.org/10.1158/0008-5472.22412180
https://doi.org/10.1158/0008-5472.22412180
Autor:
Lewis R. Roberts, Martin E. Fernandez-Zapico, Vijay H. Shah, Eric Chevet, Snorri S. Thorgeirsson, Ju-Seog Lee, Tao Song, Dehai Wu, Shaoqing Wang, Hassan M. Shaleh, Dongye Yang, Yong Fang, Yichun Chen, Abdul M. Oseini, Bubu A. Banini, Chunling Hu, Shaoshan Han, Catherine D. Moser, Michael K. Asiedu, Mengtao Zhou, Roongruedee Chaiteerakij, Alexander G. Miamen, Luciana L. Almada, Renzo E. Vera, Paola A. Romecin, Ezequiel J. Tolosa, Eriko Iguchi, Renumathy Dhanasekaran, Ikuo Nakamura, Gang Chen
Existing antiangiogenic approaches to treat metastatic hepatocellular carcinoma (HCC) are weakly effectual, prompting further study of tumor angiogenesis in this disease setting. Here, we report a novel role for sulfatase 2 (SULF2) in driving HCC ang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23c13454228018c34202a7b0dab4ca96
https://doi.org/10.1158/0008-5472.c.6508385.v1
https://doi.org/10.1158/0008-5472.c.6508385.v1
Autor:
Lewis R. Roberts, Martin E. Fernandez-Zapico, Vijay H. Shah, Eric Chevet, Snorri S. Thorgeirsson, Ju-Seog Lee, Tao Song, Dehai Wu, Shaoqing Wang, Hassan M. Shaleh, Dongye Yang, Yong Fang, Yichun Chen, Abdul M. Oseini, Bubu A. Banini, Chunling Hu, Shaoshan Han, Catherine D. Moser, Michael K. Asiedu, Mengtao Zhou, Roongruedee Chaiteerakij, Alexander G. Miamen, Luciana L. Almada, Renzo E. Vera, Paola A. Romecin, Ezequiel J. Tolosa, Eriko Iguchi, Renumathy Dhanasekaran, Ikuo Nakamura, Gang Chen
Supplementary Figure 1 Schematic representation of experimental design for HCC carcinogenesis in mice. Supplementary Figure 2 Loss of Sulf2 impairs tumor growth and incidence in DEN-model of HCC carcinogenesis. Supplementary Figure 3 Conditioned medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0c09909d62fabec63a5f3d655978eb
https://doi.org/10.1158/0008-5472.22412186
https://doi.org/10.1158/0008-5472.22412186
Autor:
Faridoddin Mirshahi, Sophie C. Cazanave, Prasanna K. Santhekadur, Bubu A. Banini, Divya P. Kumar, Abdul M. Oseini, Hae Ki Min, Liangsu Wang, Pierre Bedossa, Mulugeta Seneshaw, Cristina Alonso, Hong Ping Guan, Srinivas V. Koduru, Arun J. Sanyal
Publikováno v:
Hepatology. 73:1290-1306
BACKGROUND AND AIMS The mechanisms by which the I148M mutant variant of the patatin-like phospholipase domain-containing 3 (PNPLA3I148M ) drives development of nonalcoholic steatohepatitis (NASH) are not known. The aim of this study was to obtain ins
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
Autor:
Gabor Jarai, Abdul M. Oseini, Edgar D. Charles, Diane E. Shevell, Rebecca Collen, Benjamin E. Decato, Samir Wadhawan, John Ryan Thompson, Yi Luo, Alex Greenfield, Arun J. Sanyal
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 5, Iss 5, Pp 760-773 (2021)
Hepatology Communications, Vol 5, Iss 5, Pp 760-773 (2021)
Nonalcoholic steatohepatitis (NASH) is a major cause of liver‐related morbidity and mortality worldwide. Liver fibrosis stage, a key component of NASH, has been linked to the risk of mortality and liver‐related clinical outcomes. Currently there
Autor:
Essa A Mohamed, Nasra H Giama, Abubaker O Abdalla, Hassan M Shaleh, Abdul M Oseini, Hamdi A Ali, Fowsiyo Ahmed, Wesam Taha, Hager Ahmed Mohammed, Jessica Cvinar, Ibrahim A Waaeys, Hawa Ali, Loretta K Allotey, Abdiwahab O Ali, Safra A Mohamed, William S Harmsen, Eimad M Ahmmad, Numra A Bajwa, Mohamud D Afgarshe, Abdirashid M Shire, Joyce E Balls-Berry, Lewis R Roberts
Publikováno v:
World journal of gastroenterology. 28(35)
Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are known risk factors for liver disease, cirrhosis and hepatocellular carcinoma (HCC). There is substantial global variation in HBV and HCV prevalence resulting in variations in
Autor:
James P. Hamilton, Abdul M. Oseini, Elizabeth A. King, Aliaksei Pustavoitau, Muhammad Baraa Hammami, Russel N. Wesson, Kiyoko Oshima, Andrew M. Cameron, Ahyoung Kim, Tinsay Woreta, Benjamin Philosophe, Jacqueline Garonzik-Wang, Shane Ottmann, Mary Armanios, Ahmet Gurakar, Christian A. Merlo, Michelle C. Nguyen, Nicole Rizkalla
Publikováno v:
Liver Transpl
Short telomere syndromes (STS) are the most common premature aging disorders; mutations in telomerase and other telomere maintenance genes underlie their etiology(1). Their biology is defined by short telomere length which provokes senescence and apo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acfb20fe5e50c21d96c92e29fa6e1764
https://europepmc.org/articles/PMC8626542/
https://europepmc.org/articles/PMC8626542/